Identification of Novel Antileishmanial Chemotypes By High-Throughput Virtual and In Vitro Screening.

The identified compounds demonstrated significant inhibitory activity against Leishmania donovani and stable interactions with target enzymes. These findings suggest that the compounds could serve as promising leads for developing new treatments for leishmaniasis.